Jennifer Tjia to Drug Monitoring
This is a "connection" page, showing publications Jennifer Tjia has written about Drug Monitoring.
Connection Strength
1.679
-
Fischer SH, Field TS, Gagne SJ, Mazor KM, Preusse P, Reed G, Peterson D, Gurwitz JH, Tjia J. Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study. J Gen Intern Med. 2013 Apr; 28(4):513-21.
Score: 0.379
-
Tjia J, Field TS, Fischer SH, Gagne SJ, Peterson DJ, Garber LD, Gurwitz JH. Quality measurement of medication monitoring in the "meaningful use" era. Am J Manag Care. 2011 Sep; 17(9):633-7.
Score: 0.349
-
Tjia J, Fischer SH, Raebel MA, Peterson D, Zhao Y, Gagne SJ, Gurwitz JH, Field TS. Baseline and follow-up laboratory monitoring of cardiovascular medications. Ann Pharmacother. 2011 Sep; 45(9):1077-84.
Score: 0.348
-
Tjia J, Field TS, Garber LD, Donovan JL, Kanaan AO, Raebel MA, Zhao Y, Fuller JC, Gagne SJ, Fischer SH, Gurwitz JH. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care. 2010 Jul; 16(7):489-96.
Score: 0.322
-
Fischer SH, Tjia J, Reed G, Peterson D, Gurwitz JH, Field TS. Factors associated with ordering laboratory monitoring of high-risk medications. J Gen Intern Med. 2014 Dec; 29(12):1589-98.
Score: 0.106
-
Tjia J, Field TS, Mazor KM, Donovan JL, Kanaan AO, Reed G, Doherty P, Harrold LR, Gurwitz JH. Dementia and risk of adverse warfarin-related events in the nursing home setting. Am J Geriatr Pharmacother. 2012 Oct; 10(5):323-30.
Score: 0.094
-
Fischer SH, Tjia J, Field TS. Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: a systematic review. J Am Med Inform Assoc. 2010 Nov-Dec; 17(6):631-6.
Score: 0.082